by Typhoid fever vaccines are used prevent typhoid fever, a bacterial infection caused by Salmonella Typhi. The disease is an important health issue in many developing countries with poor sanitation systems and limited access to clean water. There are mainly two types of typhoid fever vaccines available in the market – live attenuated oral typhoid vaccines and injectable inactivated typhoid vaccines. Oral typhoid vaccines are more commonly used as they provide longer lasting protection and can be administered without the need for professional healthcare workers. The increasing prevalence of multi drug-resistant strains of Salmonella Typhi and subsequent rise in typhoid fever cases globally is a major factor driving the demand for effective vaccination programs.
The Global Typhoid fever vaccines Market is estimated to be valued at US$ 454.2 Bn in 2024 and is expected to exhibit a CAGR of 14% over the forecast period 2024 to 2030.
Key Takeaways
Key players operating in the Typhoid fever vaccines market are Linde Plc, Air Liquide, Engie, Uniper Se, Air Products Inc, Clean Hydrogen System, Cummins Inc., Toshiba Energy Systems & Solutions Corporation, Nel Asa, and Sgh2 Energy. Key players are involved in new product development and launches to strengthen their market position. For instance, in 2023, Bharat Biotech launched Typbar-TCV, an improved typhoid conjugate vaccine.
The rising awareness about typhoid vaccination programs across low and middle income countries presents significant growth opportunities for players in the market. Technological advancements are being made to develop affordable and easy to administer typhoid vaccines. For example, new oral typhoid vaccines are being developed utilizing novel live-attenuated strains and conjugation technologies to provide longer lasting protection against typhoid fever.
Market drivers
Growing impact of climate change and global warming: Climate change is causing an increase in average temperatures worldwide which is allowing infectious diseases like typhoid fever to spread to new geographic regions. rise in water scarcity and flooding events due to extreme weather also increases the risk of waterborne infections. This is a major growth driver for the typhoid fever vaccines market.
Increasing government focus on immunization programs: Multiple national level programs have been initiated by developing country governments and global health organizations to strengthen routine immunization as part of public health strategies. Increased funding and awareness generation supports higher vaccination rates driving market revenues.
Current challenges in Typhoid Fever Vaccines Market
The Typhoid Fever Vaccines Market Growth is facing challenges from emerging alternatives for treatment. Antibiotics are increasingly being used as the first line of treatment instead of vaccines. Growing anti-vaccination sentiment is also posing a problem as some parents choose not to vaccinate their children. Manufacturers need to invest more in awareness campaigns about the benefits of vaccination. The market also faces pricing challenges as these vaccines need to be affordable for widespread adoption in developing nations with a high disease burden.
SWOT Analysis
Strength: Effective in preventing typhoid infections. Multiple types of vaccines available for different age groups.
Weakness: High cost of vaccine development. Need regular booster doses for long lasting protection.
Opportunity: Growing immunization programs in developing countries. Potential for combination vaccines.
Threats: Alternatives like antibiotics gaining preference. Anti-vaccination movements limit market uptake.
Geographical regions of concentration
The Asia Pacific region accounts for the largest share of the global typhoid fever vaccines market, both in terms of value and volume. This is mainly due to countries like India, Pakistan and China having a high disease burden. These nations have immunization programs that drive vaccine usage.
Fastest growing region
Africa is forecasted to be the fastest growing regional market during the forecast period. This is because international organizations are prioritizing typhoid control on the continent. Initiatives like Gavi support introduce newer vaccines in African nations to boost immunization rates against this bacterial infection.
